← Leaderboards
Nathan Clendenen
University Of Colorado Denver
$1,216,590
Attributed
$1,216,590
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $336.6K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,216,590 · 2
By mechanism
K23$905,590 · 1
R03$311,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Xianzhong Meng$12,197,810
- Christopher Knoepke$1,612,308
- Diego Preciado$4,310,850
- Matthew Jason Greenhawt$449,901
- Ganna Bilousova$780,301
Others in their field
Other Emerging Leaders on “Mortality Risk”
- Chanza Baytop · Westat, Inc.$271,217,917
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Timothy M Willson · University Of Cape Town$32,741,597
- Arnab Kumar Chatterjee · Washington University$22,541,385
- Yunda Huang · Fred Hutchinson Cancer Center$19,258,373
- Barbara Halina Braffett · George Washington University$17,931,151
Research focus
Mortality RiskProspectiveEnvironmentMortalityPostoperative PeriodProceduresDesignEnrollmentMedical CenterMethodologyParticipantPhysiciansCohortColoradoBiomedical Referral CenterBiometryDevelopment PlansEmergency MedicineImproved OutcomeCardiacCardiac Surgery ProceduresMentorshipClinical Trials NetworkResources
Grant awards (7)
Optimizing pulsatility during cardiopulmonary bypass to reduce acute kidney injury$181,118
K23 · FY2024 · HL · contact PI
Optimizing pulsatility during cardiopulmonary bypass to reduce acute kidney injury$181,118
K23 · FY2023 · HL · contact PI
Optimizing pulsatility during cardiopulmonary bypass to reduce acute kidney injury$181,118
K23 · FY2022 · HL · contact PI
Optimizing pulsatility during cardiopulmonary bypass to reduce acute kidney injury$181,118
K23 · FY2021 · HL · contact PI
Platelet Hyperreactivity as a Therapeutic Target for Reducing Stroke in Older Adults after Transcatheter Aortic Valve Replacement$155,500
R03 · FY2021 · AG · contact PI
Optimizing pulsatility during cardiopulmonary bypass to reduce acute kidney injury$181,118
K23 · FY2020 · HL · contact PI
Platelet Hyperreactivity as a Therapeutic Target for Reducing Stroke in Older Adults after Transcatheter Aortic Valve Replacement$155,500
R03 · FY2020 · AG · contact PI